BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 20010333)

  • 21. Cardiac amyloidosis.
    Kingman A; Pereira NL
    J S C Med Assoc; 2001 May; 97(5):201-6. PubMed ID: 11381776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The premortem recognition of systemic senile amyloidosis with cardiac involvement.
    Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN
    Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Light-chain (AL) amyloidosis: diagnosis and treatment.
    Sanchorawala V
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloidosis and cardiac involvement.
    Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
    Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac amyloidosis: the heart of the matter.
    Perfetto F; Cappelli F; Bergesio F; Ciuti G; Porciani MC; Padeletti L; Moggi Pignone A
    Intern Emerg Med; 2013 Apr; 8(3):191-203. PubMed ID: 21739229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in diagnosis and treatment of AL amyloidosis].
    Zelichowski G; Lubas A; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in the diagnosis and treatment of cardiac amyloidosis].
    Jurczyszyn A; Engel A; Rajzer M; Czepiel J; Mazurs G
    Przegl Lek; 2014; 71(6):340-5. PubMed ID: 25344976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A clinical case of restrictive myocarditis due to senile-type amyloidosis].
    Martins M; Carvalho M; Prudêncio A; Ferreira JC; Seabra-Fabião A
    Rev Port Cardiol; 1997 Apr; 16(4):383-9, 352. PubMed ID: 9254127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary generalized amyloidosis with restrictive cardiomyopathy and severe chronic cardiac insufficiency].
    Borovkov NN; Amineva NV; Kovaleva GV; Sal'tseva MT; Paĭkova NN; Kuznetsov SS
    Klin Med (Mosk); 2009; 87(12):60-2. PubMed ID: 20135890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic heart failure in patients with cardiac amyloidosis].
    Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
    Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical characterisation of amyloid by endomyocardial biopsy.
    Benson MD; Breall J; Cummings OW; Liepnieks JJ
    Amyloid; 2009 Mar; 16(1):9-14. PubMed ID: 19291509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Renal amyloidosis].
    Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
    Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cardiac amyloidosis with 20-year survival.
    Fealey ME; Edwards WD; Grogan M; Dispenzieri A
    Cardiovasc Pathol; 2006; 15(6):331-5. PubMed ID: 17113011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary amyloidosis in hematological disorders.
    Cordier JF
    Semin Respir Crit Care Med; 2005 Oct; 26(5):502-13. PubMed ID: 16267701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiomyopathies in the elderly.
    Backes RJ; Gersh BJ
    Cardiovasc Clin; 1992; 22(2):105-25. PubMed ID: 1586913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
    Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement.
    Pellikka PA; Holmes DR; Edwards WD; Nishimura RA; Tajik AJ; Kyle RA
    Arch Intern Med; 1988 Mar; 148(3):662-6. PubMed ID: 3341867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary (AL) amyloidosis in plasma cell disorders.
    Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
    Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The isolated form of cardiac amyloidosis in the form of beginning infiltrative cardiomyopathy without restrictive physiology].
    Kuchynka P; Palecek T; Simek S; Lubanda JC; Elleder M; Spicka I; Jansa P; Linhart A
    Vnitr Lek; 2008 Oct; 54(10):1010-3. PubMed ID: 19009770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.